The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

Amazon wants to block you from using your own AI assistant to shop on their platform … Amazon should love this. Easier ...

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...

In this system, the implanted computer chip would not just sit on the brain, but become part of the brain. Using a technology ...

Windows 11 is a legacy desktop OS with decades-old code layered on top each other - here are five UI surfaces that Microsoft ...

Synchron was spun out of University of Melbourne by cofounders Dr Tom Oxley, Prof Nicholas Opie, and Dr Rahul Sharma in 2012.

‘We tend to oversimplify things at times,’ Informatica CEO Amit Walia says. Informatica CEO Amit Walia cautioned watchers of ...

The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

Synchron, a leader in non-surgical brain-computer interface (BCI) technology, announced today it has raised a $200 million Series D financing round. The funding will accelerate commercialization of ...

Synchron announced today that it raised $200 million in a Series D financing round to support the commercialization of its ...

The National Reconstruction fund has joined Amazon founder Jeff Bezos and other Silicon Valley heavyweights in backing ...